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ABSTRACT 
Relationship of Emotional Intelligence and Adherence to Combination Antiretroviral 
Medications by Individuals Living with HIV disease 
Suzanne Willard 
James O. McDowelle, EdD 
 
Medication usage is an intentional and purposeful means to the successful 
management of many chronic diseases.  In the treatment of the disease caused by Human 
Immunodeficiency Syndrome (HIV), adherence to medication is of particular concern in 
that any level of non-adherence, often a few missed doses, will lead eventually to the 
development of drug resistance.  Many predictors of poor adherence to HIV medications 
have been identified to be a significant factor in adherence.  Among those predictors that 
have been found to be factor include the emotional aspect affecting adherence.  
The purpose of this study was to determine the relationship between emotional 
intelligence as measured by the Mayer, Salovey, Caruso Emotional Intelligence Test 
(MSCEIT) and adherence to Combination Anti-retroviral Therapy in individuals who are 
infected with the Human Immunodeficiency Virus (HIV).  Emotional intelligence (EQ), 
is defined as the ability to (a) perceive and express emotions, (b) facilitate emotions, (c) 
understand and reason with emotion and (d) manage emotions.  It has been correlated 
with various aspects of success in life.  Adherence was measured by self-report and 
defined as less than 10% missed doses of medications.  Participants were recruited from 
an urban hospital-based HIV clinic.  
Eighty-two subjects were recruited with 52 completed data sets for analysis. 
Pearson’s r was used to analyze the data for significance and no correlation was found.  
This data set was not enough to prove significance, statistically, of the research question. 
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However, an unexpected finding of this study revealed that the overall EQ scores for this 
particular study population were markedly lower than the test norms.   
Further study would be warranted and recommended to explore the utilization of EQ in 
people at risk for HIV disease or those individuals who have the disease to further 
understand the impact that emotions and EQ have on this specific population. 
8  
 
9  
 
 
CHAPTER 1. INTRODUCTION/BACKGROUND 
 
The disease that is known as Acquired Immuno-Deficiency Syndrome (AIDS) 
was first identified as an epidemic in 1981 (CDC, June 5, 1981). Currently, there are over 
750,000 individuals with AIDS identified in the United States (CDC, 2000) and over 40 
million infected in the world (UNAIDS, 2001). The Global AIDS Policy Coalition (Mann 
& Tarantola, 1996) described lessons learned about the epidemic as: (a) No community 
or country already affected by AIDS has been able to stop the spread of the Human 
Immunodeficiency Virus (HIV); (b) HIV is spreading rapidly to new communities and 
countries around the world, and HIV will reach most, if not all, human communities; (c) 
The global epidemic becomes more complex as it matures and is composed of thousands 
of smaller, complicated sub epidemics as HIV exploits every potential avenue in society; 
and (d) HIV has demonstrated repeatedly its ability to cross all borders – social, 
economic, cultural, political and geographic – and the conditions that foster HIV spread 
are complex and changing. 
When an individual is diagnosed HIV positive, he or she experiences many 
profound emotions.  This illness, as stated by Sontag (1989), “flushes out an identity that 
might have remained hidden from neighbors, job, mates, family, and friends.” (p. 25).  In 
2002, HIV is a chronic, complex, disease.  However, since 1995, there has been a 
dramatic growth in pharmacological treatment of HIV/AIDS and has resulted in a 
dramatic decline in the death rate due to the disease(Bartlett & Gallant, 2001; Ungvarski 
& Flaskerud, 1999).  Treatment regimes often require multiple medications scattered 
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throughout the day.  The virus, however, has shown an ability to mutate at a rapid pace if 
the medications are not taken in the exact prescribed manner.  Often, in such cases, the 
virus grows resistant to the prescribed medications that are designed to help.  Medications 
will then lose their ability to adequately control this virus.  Leading more to the 
importance of adherence to the control of this disease. 
The literature review demonstrated that there are patterns of adherence addressing 
why some individuals take medicines and others do not.  Chesney (2000) in her review of 
adherence and HIV medications has reported that the relationship with the health care 
provider, simply forgetting, being too busy, being out of town, being asleep, being 
depressed, the medications having adverse side effects, and being too ill to take the 
medications were related to adherence.  Adherence is not the only aspect of this disease 
that has demanded innovative and creative measures to improve health outcomes. 
HIV has challenged health care systems.  Clinical systems have been designed to 
respond to the multiple demands that this disease has had upon society.  Programs in the 
United States have been funded that provide social support in addition to clinical services 
most notably thru the Ryan White Comprehensive AIDS Resources Emergency (CARE) 
Act. In 1990, the CARE Act was signed into law with the purpose to improve the quality 
and availability of care for people with HIV/AIDS and their families. Amended and 
reauthorized in May 1996, the Act is named after an Indiana teenager, Ryan White, who 
became an active public educator on HIV/AIDS. He died of AIDS the same year the 
legislation was passed (U.S. Department of Health and Human Services, 2002).   
As health care systems have been pushed by this disease to be creative, methods 
to improve adherence to medications also requires creative approaches to improve 
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patient’s lives.  Programs have been designed to improve these patterns of adherence.  
One recent study has shown that attending to an individual’s emotional responses would 
improve the ability to adhere to regimes (Pradier et al., 2002).  As an individual provider 
this has proven to be frustrating in seeking some method to help patients adhere to 
medications.  
Emotional intelligence (EI) is an emerging body of knowledge that has promise in 
exploring issues of adherence. Emotional intelligence can be defined as: 
“…an ability to recognize the meanings of emotions and their 
relationships, and to reason and problem-solve on the basis of them.  Emotional 
intelligence is involved in the capacity to perceive emotions, assimilate emotion-
related feelings, understand the information of those emotions, and manage them 
(Mayer, Caruso, & Salovey, 1997, p.267).  
The literature review will demonstrate that EI is an area that has value in further 
understanding  why some individuals are able to successfully adhere to medications and 
why others cannot. Pradier (personal communication, February 26, 2002) stated that it 
would have been important to have a tool to identify different aspects of emotions to 
better address the needs of the subjects in his study.  Assessment of emotional 
intelligence may provide such a tool.  
Simply put, health care providers need to understand why individuals take or fail 
to take their medications.  Applying the emotional intelligence model to the concept of 
medication adherence may provide more understanding of how providers can help their 
patients take their medications in order to improve their quality of life as well as extend 
their lives.  
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CHAPTER 2. REVIEW OF LITERATURE 
 
HIV causes a serious chronic disease that requires a complex treatment regime.  
HIV invades the immune system of the human body.  Infection occurs through contact 
with blood and body fluids, most often through sexual contact. The virus can also be 
passed from an infected woman who is pregnant to her children during pregnancy, 
delivery or through breast-feeding (UNAIDS, 2001). HIV destroys a specific white blood 
cell, the CD4 cell. HIV will cause a constellation of symptoms that include infections to 
common pathogens that will cause no symptoms in a healthy individual.  These common 
pathogens are ubiquitous, meaning that they are present in most humans.  In most 
humans, the immune system does not allow the pathogens to cause disease.  Disease-
specific symptoms result in what is commonly identified as Acquired Immuno-
Deficiency Syndrome (AIDS). A health care provider using certain clinical or laboratory 
standards makes the diagnosis of HIV/AIDS.  Table 2.1. is a listing of the opportunistic 
infections that causes a diagnosis of AIDS.  Under-treated or untreated HIV disease will 
always cause the individual patient to be faced with an AIDS defining illness. 
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Table 2.1. Clinical and Laboratory Standards for AIDS Diagnosis  
Candidiasias of esophagus, trachea, bronchi, or lungs 
Cocciodiomycosis, extrapulmonary 
Cryptococcosis, extrapulmonary 
Cryptospordiosis with diarrhea > 1 month 
CMV of any organ other than liver, spleen or lymph nodes 
Herpes simplex with ulcer > 1 month or bronchitis, pneumonitis, esophagitis 
Histoplasmosis, extrapulmonary 
HIV-associated dementia, interfering with occupation or activities of daily living 
HIV-associated wasting: Involuntary weight loss >10% of baseline  
Isoporosis with diarrhea > 1 month 
Kaposi’s sarcoma in patient under 60 years 
Lymphoma, Burkitts, immunoblastic, primary CNS 
Mycobacterium avium, disseminated 
Mycobacterium tuberculosis, pulmonary, extrapulmonary 
Pneumocystis carinii pneumonia 
Pneumonia, recurrent-bacterial (>2 episodes in 12 months) 
Progressive multifocal leukoencephalopathy 
Salmonella septicemia, recurrent 
Toxoplasmosis of internal organ 
Wasting syndrome due to HIV 
CD4 less than 200/mm 
(Bartlett & Gallant, 2001) 
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Pharmacological treatment of AIDS has dramatically improved since 1995 with 
the introduction of the protease inhibitor (Bartlett & Gallant, 2001; Ungvarski & 
Flaskerud, 1999).  Treatment regimes require multiple medications scattered throughout 
the day and treatment is often recommended when there are few evident symptoms or 
manifestations of the disease (U.S. Department of Health and Human Services, 2001). 
Good response to any medication occurs when there is enough of the medication in the 
blood stream for the medication to be effective.  Therefore, when the level of the drug is 
not in the system long enough or the dosage is not correct or if a dosage has been missed, 
the level of circulating medication in the body decreases.  When this occurs, the target for 
the drug, either a bacteria or a virus, will be able to continue to grow.  Medications that 
are used against any infection usually target a piece of the bacteria or virus that is 
essential to its reproduction.   Because of the tenacity of the HIV virus and the need to 
target multiple parts of the virus with many medications, pharmacological treatment of 
HIV is commonly referred to as “Highly Active Antiretroviral Therapy” or HAART.  
However, issues of adherence and emerging viral resistance occurs even with perfect 
adherence, HAART may be a misnomer.  Therefore, for the purpose of this paper, 
antiretroviral treatment will be referred to as CART (combination antiretroviral therapy). 
CART requires the solution of many complex issues to be successful.  In fact 
adherence to medications frequently have posed a challenge for both patient and 
provider.  Medications have been used throughout time to treat illness.  (Katzung, 1998). 
A drug that is used for therapeutic purposes brings about a change in biologic function 
through its chemical actions.  In viruses, such as HIV, drugs act on specific proteins that 
are necessary for the virus to replicate and inhibit them in their ability to reproduce.  The 
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HIV virus is a parasite; its’ life depends upon the host.  Drugs used against viruses must 
block entry into the host cell or be active inside the host cell (Safrin & Chambers, 1998).  
Research on drugs that have been designed to work on HIV have demonstrated that there 
needs to be several different types of anti-virals to effectively control viral replication 
(Bartlett & Gallant, 2001; Safrin & Chambers, 1998).  
 
2.1 HIV disease 
 
2.1.1Epidemiology, pathophysiology and treatment. 
The AIDS epidemic has challenged health care systems on several levels. First, in 
the way care is delivered and second, in the way that treatments have been identified and 
utilized.  Treatments have come to general use quicker than other drugs because of the 
urgency of the disease and the impact of activists (Julie Davids, ActUP,  personal 
communication, April 22, 2001). The advances in the knowledge of managing AIDS 
have been rapid.  However, biological and social scientists are still working diligently to 
seek an understanding of the complexities of this disease.  Much has been learned, but 
twenty years into the epidemic, treatment and management are still considered to be in its 
infancy (Harrington & Carpenter, 2000; Miramontes, 1999; Ungvarski & Flaskerud, 
1999). 
Table 2.2 is a definition of terms that are frequently associated with HIV/AIDS.  
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Table 2.2 Definitions of Terms 
Term Description 
  
CD4/T-Cell A type of white blood cell that is considered a 
surrogate marker to determine HIV-related 
immune dysfunction 
 Viral load  Measurement of the amount of virus circulating in 
the blood stream at the point that the test is taken.   
Viral Resistance Viral mutation in its replication process to a point 
at which the medications will not work 
AIDS Disease caused by HIV with severe immune 
suppression and opportunistic infections. 
(Bartlett & Gallant, 2001) 
 
HIV is a retrovirus that enters and infects others through contact with bodily 
fluids. The most common route of contact is sexual.  A retrovirus is a type of virus that 
has the ability to reverse the usual flow of genetic information for the purpose of 
reproduction.  Transmission occurs through various routes where an individual is exposed 
to fluids such as human blood, vaginal secretions, semen and breast milk. (Bartlett & 
Gallant, 2001; Ungvarski & Flaskerud, 1999). The life cycle of the virus is as follows: (a) 
the virus attaches itself to the CD4, (b) it inserts itself into the cell and begins to 
reproduce, (c) it integrates newly synthesized DNA into the host cell DNA, and 
transcribes and translates the viral genetic message into viral protein, (d) then releases the 
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virus out of the host cell to go and infect other host cells (Bartlett & Gallant, 2001; 
Ungvarski & Flaskerud, 1999). 
As many as 10 billion new HIV virions are produced daily in an HIV-infected 
person (Feinberg, 1996).  However, disease progression has a variable course.  Often 
there is a long period of time without physical symptoms that requires treatment before 
the advent of an AIDS defining illness.  It can take up to an average of 10 years before 
the opportunistic infections that signal an AIDS diagnosis occurs (Bartlett & Gallant, 
2001). Infection with HIV has a highly individualized course. There are some in whom 
the disease progresses rapidly, causing symptoms in as little as a few years after 
infection. While some individuals rapidly progress, others do not and are classified as 
long-term non-progressors (Ungvarski & Flaskerud, 1999). Many factors explain the rate 
of disease progression.  Among these are the amount of circulating virus and its 
virulence, and how the host’s immune system fights the virus’s replication.  There are 
other factors that may impact the host’s immune system in either a positive or negative 
manner: e.g. stress (Bartlett & Gallant, 2001; Ungvarski & Flaskerud, 1999).  
The primary or acute HIV infection phase is the period of time following initial 
entry of HIV into a person’s body.  Acute infection sees the virus replicating in 
staggering numbers in the blood.  The initial immediate immune response symptoms are 
often overlooked and diagnosis does not readily occur.  Early symptoms include 
lymphadenopathy (swollen glands), fevers, and fatigue.  The symptoms of initial 
infection have a median duration of 14 days.  Once the immune system mounts an initial 
response to this new pathogen, the system causes the virus to slow its replication process, 
slowly destroying the CD4 cell.  CD4 cells at the 200 level will demonstrate signs of 
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immune suppression.  The most commonly seen early symptoms include thrush (a fungal 
infection in the mouth), weight loss and peripheral neuropathy (numbness and tingling in 
the hands and feet) (Bartlett & Gallant, 2001; Daar, 1998; Ungvarski & Flaskerud, 1999). 
The immune system is a marvelous and complex entity that has the ability to 
recognize foreign intruders and mount a defense.  The immune system produces cells that 
surround the intruder and either compartmentalizes it, rendering it helpless or completely 
removes and destroys the microbe. An example of a microbe that is rendered helpless is 
the microbe that causes pneumocystis carinii pneumonia (PCP). Once the immune system 
is greatly impacted and no longer has the capability of confining this microbe, it 
resurfaces and causes symptoms, usually a severe pneumonia, which can easily lead to 
death (Bartlett & Gallant, 2001). The virus attacks a key part of the immune system – the 
CD4 cell.    The virus uses these cells as a factory in which it can replicate and cause cell 
destruction.  This will lead to the ultimate destruction of the immune system and cause a 
phenomenon known as immunosuppression (Fauci , Panatleo, Stanley, & Weissman,. 
1996). This period of time in which the cells are being destroyed is called one of 
quiescence and there are no obvious physical symptoms.  Disease progression can be 
monitored thru laboratory tests to count the number of CD4 cells.  In a healthy human 
this number is 500 to1500 cells per cubic millimeter of blood (Bartlett & Gallant, 2001; 
Ungvarski & Flaskerud, 1999).  Opportunistic infections become evident when an 
individual’s CD4 cells are 200. (Bartlett & Gallant, 2001) 
As earlier noted, disease progression occurs at a variable rate.  From time of 
infection, people with HIV often do not show any AIDS-defining illnesses for 6 – 10 
years (Pantaleo, Grazioai, & Fauci, 1993). Several variables have been related to disease 
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progression.  Biological variables include amount of circulating virus, age of host and 
reinfection with more virus, usually thru sexual interactions with other individuals with 
HIV (Bartlett & Gallant, 2001). Disease progression will also occur when an individual is 
not able to adhere to pharmacological treatments (Paterson, et al. 2000). Viral resistance 
is a phenomenon that occurs when the virus, which is replicating at a rapid pace, 
experiences genetic mutations thru the process of replication (Deeks, 2000). Resistance 
rapidly occurs when there are inadequate blood levels of drug therapy circulating, 
therefore allowing the virus to replicate in the presence of the medications.  The most 
common cause of resistance is the inability to adhere to the often-complex regimes 
(Chesney, Morin, & Sherr, 2000). Many regimes require frequent pill doses throughout 
the day.  The medications require precise adherence to a complex daily regimen 
involving up to 18 pills that often have unpleasant side effects.  It is obvious that 
adherence is a challenge for all affected.    
 
2.1.2 Treatment and adherence 
Treatment for many people living with HIV, many of whom are without physical 
disease symptoms includes Combination Antiretroviral Therapy (CART) for the rest of 
their lives (Bartlett & Gallant, 2001; U.S. Department of Health and Human Services, 
2001). The ability of the patient to adhere to the regimen is essential for successful 
treatment. The terms adherence and compliance are often used interchangeably in the 
literature.  Compliance is a synonym for obedience and is a value-laden term.  The 
Hippocrates statement in Turner’s and Hecht’s editorial   “The physician must….make 
the patient…cooperate” (2001 p. 1004) is filled with paternalism that might affront 
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modern patients as well as their health care providers; however, this term is still in use. 
For the purpose of this study, the term, adherence, will be utilized.  Adherence is defined 
as the ability to take medications as prescribed. 
Effective treatment of HIV disease has been used since the introduction of the 
protease inhibitor in 1996 (Deeks, 2000). Literature on adherence research in HIV disease 
is limited in comparison with other diseases because treatment is still in its infancy. The 
advent of efficacious treatment in 1996 with combination therapy and the challenges that 
this presented gave rise to this area of research.   What is known is that excellent 
adherence has been shown to increase the likelihood of sustained control of the virus, 
which is important for reducing HIV-related morbidity and mortality.  Poor adherence 
has been shown to increase the likelihood of medication failure and has been associated 
with increased morbidity and mortality. Also, poor adherence leads to the development of 
drug resistance, therefore, limiting the effectiveness of therapy (Chesney, 2000; Deeks, 
2000; Harrington & Carpenter, 2000). 
A high degree of adherence is necessary for optimal virologic suppression with 
CART; several studies as reviewed by Paterson, et al. (2000) have shown that 90-95% of 
doses must be taken for optimal suppression, and lesser degrees of adherence are more 
often associated with virologic failure.  There is no conclusive evidence that the degree of 
adherence required varies with different classes of agents or different specific 
medications in the CART regimen (Paterson, et al. 2000).  
Imperfect adherence is common. Stephenson, Rowe, Haynes, Macharia, & Leon 
(1993), in a review of all medication adherence, noted that there is an approximately 50% 
compliance rate with long-term self-administered therapy in any chronic disease. In 
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studies of adherence to HIV treatment, surveys have shown that one-third of patients 
missed doses within 3 days of when the question concerning adherence was asked 
(Ickovics  & Meisler, 1997).  The reasons for missed doses were predictable and included 
forgetting, being too busy, being out of town, being asleep, being depressed, having 
adverse side effects, and being too ill (Chesney, 2000). One fifth of HIV infected patients 
in one urban center never filled their prescriptions. Many people infected have no home, 
nor do they have access to adequate medication storage. This may lead to poor adherence, 
but not without exception; one recent program achieved a 70% adherence rate among the 
homeless utilizing flexible clinic hours, accessible clinical staff, and incentives 
(Bangsberg, 1997).  
Many predictors of poor adherence to HIV medications have been identified. 
These include (a) poor clinician-patient relationship, (b) active drug and alcohol use, (c) 
active mental illness, particularly depression, (d) lack of patient education, (e) inability of 
patients to identify their medications, and (f) lack of reliable access to primary medical 
care or medication (Chesney, 2000; Shapiro, et, al; 1999; Stone et al., 1998; Tedaldi, 
Willard, Gilmore, Holdsworth, & Axelrod, 2002). Other sources of instability that may 
influence adherence include domestic violence and discrimination (Shapiro, M. et, al; 
1999). Medication side effects also may cause poor adherence (Max & Sherer, 2000). 
Factors such as gender, race, socio-economic status, educational level, and a past history 
of drug use do not reliably predict poor adherence. Conversely, a higher socioeconomic 
status and educational levels and a lack of a history of drug abuse do not predict adequate 
adherence (Sherer, 1998).  
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Predictors of good adherence to HIV medications have also been identified. These 
include: (a) availability of emotional and practical life supports, (b) the ability of patients 
to fit the medications into their daily routine, (c) the understanding that poor adherence 
leads to resistance, (d) the recognition that taking all medication doses is important; and 
(e) feeling comfortable taking medications in front of people (Cheever, 1999). It is 
evident that many factors relating to adherence and non-adherence have strong emotional 
overtones, e.g. a history of depression, relationships with the health care provider and the 
stigma of this disease.  Pradier and colleagues’ (2002) intervention has shown that when 
the emotional aspects of HIV and adherence were addressed, there was a significant 
improvement in adherence and improved viral control.   
There is a lack of agreement on the best method to assess adherence.  Many 
studies have used drug levels, pill-counting devices and counting procedures (Arnsten et 
al., 2001; Liu et al., 2001; Stephenson et al., 1993). Research in this area continues as a 
good measure of adherence has yet to be agreed upon.  
It is important for health care providers to gain understanding of why individuals 
take their medications.  Because of the many factors related to adherence associated with 
adherence, the emotional intelligence model may provide further insight into medication 
adherence and may provide more understanding to helping patients take their 
medications.   
 
2.2 Emotions and HIV 
There is evidence (Robinson, 2000) that stress may play a role in HIV disease 
progression by increasing viral replication and suppressing immune response.  Ungvarski 
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(2000) states, “active coping is believed to have beneficial health effects”(p. 35) as it 
relates to HIV/AIDS as well as all disease states.  Active coping includes (a) problem 
solving activity, (b) increased expression of emotions, (c) altering one’s lifestyle, and (d) 
taking control of the management of one’s health and well-being.  He further draws 
attention to the benefit of emotional expression.  Finding positive pathways to emotional 
expression thru groups, professional and social, family, friends is beneficial as 
demonstrated by Cole, Kemeny, & Taylor (1997).  Cole and colleagues also reported that 
expression of basic emotions was related to increased immune function as measured by 
the CD4 cell count. 
Being diagnosed with HIV infection has a large emotional aspect (Stevens & 
Doerr, 1997).  Individuals often feel that they have been punished for past digressions of 
societal mores.  This sense of punishment and society’s viewpoint of homosexuality and 
drug abuse perpetuate the high level of stigma associated with the disease.  As this is 
predominately a sexually transmitted disease, it is a disease of individuals who have sex 
(Ungvarski & Flaskerud, 1999).  Stevens (1997) found that for women with HIV, just 
being informed of the diagnosis of HIV was a traumatic event, carrying with it elements 
that are common to other types of trauma, especially, perceived threat to one’s life and 
perceived responsibility for the deaths of others.  Reactions of shock, fear, and anguish 
are common when an individual first learns of their infection. The response of society to 
the information is devastating as well.   There is a lack of research on the connection 
between the emotions of the disease and the subsequent ability to manage the disease.  
The secrecy of the diagnosis of HIV is omnipresent, adding to the stress of living 
day to day with HIV.  Laws have further reinforced this secrecy in that many health 
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departments are unable to report the number of individuals infected with HIV disease as 
they do with other communicable disease (Leibowitz, Kessler, & Frumkin, 1999). 
Adherence to complicated medication regimes, negotiating safe sexual practices, and 
health promotion and wellness activities are easily compromised by the complexities of 
the lives of HIV positive individuals.  For example, one patient stated: “Don’t write the 
name AZT (a commonly used drug) on the pill bottle, I don’t want anyone to know in my 
house” (Anonymous, personal communication, September 25, 2001). 
As mentioned previously, the reactions of an individual to being informed that 
they are HIV positive are filled with emotions.  The women in Stevens & Doerr’s study 
(1997) stated that the  
“trauma of HIV discovery was an epiphany; a confirmation or calamity 
and the impact often took its toll in misery, escalated drug use, suicidal feelings 
and destabilization of relationships… ‘He (the doctor) told me I was infected with 
the HIV virus. I thought he had sentenced me to die’”(p.4). Another woman in the 
same study said, “I thought I was going to drop dead at any moment.  I lived like 
that for a couple of years”(p.4). One third of these women reported that they 
wanted to be dead.  Another stated: “I didn’t feel good after they told me.  I tried 
everything I could to off (kill) myself, to leave here.  But, I always woke up.  I am 
still here.  I should have left.  Sometimes I feel like that right now”  (p. 11).  
 
What can be thought of as short-term subjective experiences of emotional trauma 
– confusion, panic, inconsolable grief – will continue into a prolonged period of distress 
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(Van der Kolk, McFarlane, & Weisaeth, 1996). One could wonder what is the impact on 
the management of this disease when the negative feelings are so strong. 
Grassi et al (1999) reported that patients’ emotional adjustment to HIV infection 
is a complex phenomenon involving a number of variables including individual as well as 
psychosocial factors.  Their study compared three groups: individuals with HIV, those 
with other serious diseases, and those with cancer.  They found that patients with HIV 
disease had a higher emotional burden when compared with the other two groups.  
Pakenham and colleagues (1996) reported in their research study that distressing 
emotions was the most frequently reported problem.  Sadness was a common emotion.  
They also reported that both the participants without symptoms as well as the 
symptomatic participants reported a full gamut of emotions and that the groups differed 
little with respect to frequency and type of emotion reported. 
The full impact of emotions and their effect on managing this disease is poorly 
understood.  Pradier et al (2002) found that adding a counseling component to the 
educational adherence program that included addressing emotions resulted in a positive 
outcome, a significant reduction of HIV viral load. 
 
2.3 EI as a theoretical framework 
2.3.1 History of the study of emotions 
 Humans have been long been intrigued with the concept of the impact of emotion 
on human existence.  The ancient Greeks noted,  “that mentation, rationality, foresight 
and decision making can be hijacked by the pirates of emotion” (Cacioppo, 1999, p. 
194). Plato and Aristotle wrote about the internal conflicts among thoughts, desires and 
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emotions (Lazarus, 1999).  Lazarus defined the emotions as a  “a complex organized 
system consisting of thoughts, beliefs, motives, meanings, subjective bodily experiences, 
and physiological states, all of which arise from our struggles to survive and flourish by 
understanding the world in which we live” (p. 100). There has been discussion 
throughout the ages on how to diminish the influence of emotion on decision-making and 
behaviors (Cacioppo & Gardner, 1999; Lazarus, 1999). 
The work of Dr. Peter Salovey and Dr. John Mayer in the early 1980’s first 
described the concept that is now known as Emotional Intelligence (EI).  Dr. Peter 
Salovey is currently at Yale University and Dr. John Mayer is currently at the University 
of New Hampshire.  Their work is based upon a long history of the study of intelligence 
and its correlation with abstract thinking (Mayer, 2001b, 2000). 
EI, while studied and written about in academic literature, was relatively 
unknown to the general public until the mid-1990’s.  The concept was brought to the 
public’s attention in a popular book Emotional Intelligence (Goleman, 1995a).  EI was 
further propelled into the popular culture thru the press, via Time magazine (Gibbs, 1995) 
and Goleman’s (1995a, 1995b) related work.  These articles reviewed the importance of 
EI as it pertained to success in school and in the workplace and stated that it was an 
overlooked part of personality.  Goleman (1995a) also proposed that EI could be easily 
learned or acquired and therefore improved.   
As an ability, EI has been explored and further defined by Mayer, Salovey and 
Caruso (2000).  They described EI as an ability that arises from a union of the cognitive 
and emotional system. Mayer, Salovey and Caruso (2000) conceptualize EI into a four-
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branch model: (1) perceiving emotions, (2) facilitating thought, (3) understanding 
emotions and (4) managing emotions.  See Table 2.3.  
 
Table 2.3 Overview of the Four-Branch Model of Emotional Intelligence  
Branch name Brief description of skills involved 
Perceiving Emotions 
(Branch 1) 
The ability to perceive emotions in oneself and others, as well as 
in objects, art, stories, music and other stimuli. 
 
Facilitating Thought 
(Branch 2) 
The ability to generate, use, and feel emotion as necessary to 
communicate feelings, or employ them in other cognitive 
processes 
 
Understanding 
Emotions (Branch 3) 
The ability to understand emotional information, how emotions 
combine and progress through relationship transitions, and to 
appreciate such emotional meanings. 
 
Managing Emotions 
(Branch 4) 
The ability to be open to feelings, and to modulate them in 
oneself and others so as to promote personal understanding and 
growth. 
 
 (Mayer, Salovey, & Caruso, 2002, p.7) 
The cognitive system carries out abstract reasoning about emotions, while the 
emotional system enhances cognitive capacity (Mayer, 2000, 2001a; Mayer, Salovey, 
Caruso, & Sitarenios, 2001). In other words, emotional intelligence is the ”ability to 
regulate emotion in a way that enhances living”(Gibbs, 1995, p. 45).   
Mayer and Salovey (2000) view EI as operating across both cognitive and 
emotional systems. They also believe that one can use emotions to improve thinking or 
cognitive processes.    
The mind-body connection of EI is important for the purpose of this study.  The 
core of emotions is centered in the limbic system and the amygdala deep within the brain.  
The limbic system is composed of several brain structures that have been associated with 
emotions as well as with memory. The amygdala is an almond sized structure in the 
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midbrain (LeDoux, 2000; Pert, 1997).  It is within these areas that the catecholamines, 
adrenaline and nor adrenaline, are regulated.  These chemicals mobilize the body for an 
emergency and provide memories of these events (Golman, 1995). That is, when an 
individual has been exposed to trauma, physical or emotional, this system becomes 
hyper-reactive secreting large doses of these chemicals in response to situations that hold 
little or no threat but somehow are reminders of the original trauma.  Changes in these 
systems are thought to underlie trauma symptoms and include anxiety, fear, being easily 
upset and aroused, readiness for fight or flight and the indelible encoding of intense 
emotional memories (Goleman, 1995; Pert, 1997).  A defining characteristic of a 
traumatic event is the ability to provoke fear, helplessness or horror.  People with Post-
Traumatic Stress Disorder (PTSD) have distinct types of symptoms that include re-
experiencing the event and avoidance of reminders of the event (Yehuda, 2002).  While 
there are no conclusions that state that learning a diagnosis of HIV is the same as an 
event that may trigger PTSD, the similarities, of the emotional responses (i.e., avoidance 
of reminders of the event) cannot be denied.   
Studies also have shown that there are high incidences of people who are HIV 
positive who also have a history of abuse (Cohen et al., 2000;Gregonis  & Grant, 1994; 
Jinich, S., et al 1996). Heim and colleagues (2000) have shown that women with a history 
of childhood abuse exhibited increased pituitary-adrenal and autonomic responses to 
stress compared with controls. This is likely related to an increased risk for adulthood 
psychopathological conditions.  These are the same pathways that LeDoux (2000) spoke 
about in his work on emotions. Several studies have illustrated strong sympathetic 
nervous system reactivity to the expression of basic emotions (fear, anger, surprise, 
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disgust, happiness and sadness) that are related to increased immune function and 
enhanced mental and physical health (Cole,  Kemeny & Taylor, 1997; Gross 1989). 
These studies cited interactions among emotional expression, strong autonomic reactivity 
and increased immune response.  Some studies (Cole, Kemeny  & Taylor, 1997; Miller, 
& Cole 1998) have demonstrated that emotional stressors – secrecy, social identity and 
social relationships can have a deleterious effect on physical and mental health.  Trinidad 
and Johnson (2002) concluded that adolescents with high EI might possess a greater 
ability to avoid tobacco and alcohol use that would have a deleterious effect on their 
health.  
 
2.4 Emotional intelligence and adherence 
While there have been studies, as noted previously, on the emotions of living with 
HIV, and a correlation of EI and health behaviors, little research has been conducted on 
the correlation of emotional intelligence and the HIV positive individual’s ability to 
adhere to their medication regime. Communication with EI researchers and authors, Dr. 
Peter Salovey of Yale University (personal electronic communication July 5, 2001) and 
Dr. David Caruso (personal communication, February 8, 2002) further confirmed the 
importance of this research question. Salovey wrote, “most traditional variables 
that…have studied have not been good predictors of adherence. Why not try EI?” The 
literature on adherence to ART medication regimes has not identified ideal measures to 
improve adherence.  Therefore innovative approaches to study this phenomenon needs to 
be explored. 
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The application of EI to success in disease management was explored by Samar 
(2001).  The diabetics in this study demonstrated a correlation between EI and disease 
self- management skills. Samar (2001) concluded that there is a relationship between 
disease management practices in diabetics and EI as measured as an ability using the 
Multifactor Emotional Intelligence survey (MEIS).  Diabetes is a chronic illness that 
requires daily medications to control symptoms as well as the disease itself.  Untreated or 
poorly managed diabetes, like HIV, can have catastrophic results.  Samar used Mayer and 
Salovey’s MEIS as a test to see the relationship between EI and disease management.  
The MEIS is an earlier version of Mayer and Salovey’s measure of emotional intelligence 
(EQ).  As diseases, there are similarities between the management and treatment of these 
two chronic illnesses, diabetes and HIV.   Samar’s research provides a model study 
similar to the study proposed in this paper. She recommended that clinicians become 
more aware of the multidimensional nature of self-management of disease and to avoid 
the negative connotations of common words used in clinical care, such as  - non-
adherence and non-compliance.  In Samar’s study (2001), a significant relationship was 
found between self-management and one branch of the measure of emotional intelligence 
the MEIS (r=.335, p=.001) (p.69).  Samar’s (2000) research concluded that while there 
was a correlation of EI  and disease management (Pearsons r=.21, significance p=.048) 
(Samar, 2000, p 69), emotional intelligence provided an effective framework to link self-
management practices by measurable abilities.  Salovey (2001a) also has given thought to 
the connection between EI and disease responses.  He wrote “EI appears to be central in 
maintaining good health” (p. 184).  
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This study proposed to look at adherence from an emotional perspective that has 
not been extensively studied.  If there is a positive relationship between EI and 
adherence, then educational efforts could be designed to improve EI with the expected 
outcome to improve adherence.   
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CHAPTER 3. METHOD 
This study investigated the relationship between EI and medication adherence in a 
population of HIV positive individuals.  The questions for study were: what is an 
individual’s emotional intelligence score and, is there a relationship between that score 
and the ability to adhere to medication regimes as measured by self-report?   
 
3.1 Significance 
The significance for the study was two fold: (a) that the EI scores of HIV positive 
individuals may bring to light another aspect of living with this potentially devastating 
chronic illness that was previously fully understood.  And (b) health care providers may 
have been able to modify their practice and patient education methods to increase an 
individual’s potential to improve adherence, given information related to EI. 
 
3.2 Variables 
The independent variable for study was emotional intelligence as measured by an 
ability scale; the Mayer, Salovey, Caruso Emotional Intelligence Test (MSCEIT).    The 
dependent variable was self-report of adherence to medication.  
 
3.3 Sample 
A sample was drawn from patients who present for an appointment at the 
Partnership Comprehensive Care Practice in the Division of HIV/AIDS at Drexel 
University, formerly known as MCP/Hahnemann University.  This is a health care 
practice that provides both primary as well as specialty care for individuals with for HIV 
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disease.  The clinic is situated centrally within the city of Philadelphia, a large 
metropolitan area in the northeastern part of the United States.  Over 1200 individuals 
receive their medical care at this facility, in the course of a year.  Sixty percent are men 
and 40 percent are women; the population is predominantly African American and Latino 
(90%).   The demographic profile of this population mirrors the epidemiology of HIV 
disease on a national level.  Services that are provided include primary medical care as 
well as specialty care.  Case management services, nutritional counseling, 
pharmacological counseling and mental health services are also available.   There is a 
team of seven health care providers, 4 physicians and 3 nurse practitioners. 
Approximately 50 patients are scheduled for providers each day.  The clinic is open five 
days a week and services are also available on a walk in basis.  The clinic also has a large 
research component of industry sponsored clinical trials and the clinic population is 
accustomed to participation in research studies.  The researcher is one of the health care 
providers in this location. To control for researcher bias and to maintain the safety of the 
patient provider relationship, none of the researcher’s patients were enrolled in the study. 
The study was designed to use a sample size of 100.  This number was selected 
because a power analysis demonstrated that this number would be sufficient for this study 
to attain a power level of .80. (Polit-O'Hara, Hungler, & Polit, D.F.,1999). This 
calculation was based upon Samar’s (2001) results.   Because the emotional aspects of 
HIV disease as demonstrated in the literature review is more evident than those with 
diabetes, this further demonstrated the need for this sample size. 
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3.4 Data collection plan 
Subjects were recruited at the clinic by two primary methods: (a) flyers were 
distributed to the clinic with a telephone number for the prospective subject to call the 
researcher and (b) clinic staff received information on the project and were to inform the 
clients of the flyers.  Once the participants are contacted, and a meeting time and place 
arranged that was mutually acceptable, the procedures of the study and the informed 
consent document were reviewed and explained by the researcher.  If the subject agreed 
to the study, and met the study criteria, the subject signed the consent form and a copy 
was given to them for their records and another was kept on file by the researcher.    
Participants were to be paid $25 when they completed the study as remuneration for any 
expenses that may incur in order to participate.  The expected expenses would include 
transportation and childcare costs.   
 
3.5 Instruments 
Data included the ability measurement of EI, the MSCEIT, and a survey that 
included descriptive data for each participant in the sample. The MEISCT is based upon 
Mayer and Salovey’s model of emotional intelligence.  The MEISCT is an instrument 
that is designed to yield a total emotional intelligence score as well as individual scores.  
The individual scores are for each of the four branches of emotional intelligence: 
Identifying Emotions, Using Emotions, Understanding Emotions and Managing 
Emotions.  Test instructions stated that thirty minutes would be required to complete the 
test.  Norms for this test were based upon a sample of over 5,000 North American 
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individuals.  Patient identifiers were shielded by the use of a coding system.  The 
MSCEIT has been studied with individuals of varying ethnic backgrounds and education.  
Normative data was collected from over 50 research sites.  It has been normed with 
individuals of both genders who are 17 years of age and older.  There are several scores 
produced by the MSCEIT, the overall, two area scores, four branch scores and eight task 
scores.  
 
3.6 Reliability of tools 
Reliability represents the consistency of the measures obtained.  Reliability 
testing is a measure of the random error in a measurement technique (Weirsma, 2000)  
The MSCEIT has a full-scale reliability of alpha = .91.   It has been demonstrated 
that it is highly reliable test at the Branch and Full-scale levels.  There are subtasks of this 
test that are available but were not used for the purpose of this research because they are 
considered to be somewhat less reliable(Mayer et al., 2002). 
 The measure of adherence is still an ongoing discussion in the literature 
and while there is no accurate measure of adherence that is agreed upon, the literature 
search done for the purpose of this study demonstrated that regardless of measures 
utilized, a recall of the past 7 days correlated with many different methods of assessment.  
It therefore was adequate and was used for that purpose in this study.   
After discussion with David Caruso, (personal communication, February 8, 2002) 
the total EQ score and the four branch scores will be used for the purpose of this study. 
Task scores are less reliable measures of emotional intelligence and are subject to great 
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variation (Mayer et al., 2002).  The researcher, who has undergone training and has 
obtained certification, will administer the test.    
The participant, via pen and paper, will complete the demographic information.  
Adherence will be assessed, using the method proposed by Liu and colleagues (Liu et al., 
2001). The following questions were included: 
1. “Many people don’t take their medication perfectly all the time.  Over the past 
7 days, how many times did you miss a dose of your medication?’  
2. “When was the last time that you missed any of this medication?”  
3. And another question used a visual analog scale from one to 10 with always, 
sometimes and never aligned with the numbers.  The score was decided based upon the 
mean of question 1 and 3.  
Adherence will be presented as either the subject reported that they were adherent 
or they missed doses in the previous seven days. 
 
3.7 Safety and confidentiality 
Institutional Review Board approval was sought  from the researcher’s academic 
institution, Drexel University which also is the review board for the clinic.   All subjects 
completed and receive a copy of the informed consent to participate in the research study.  
Subject confidentiality was maintained by assigning a code to each participant.  The code 
was on a subject information sheet that will contain contact information as well as the 
individual’s identification.  Data integrity was maintained by keeping all information in a 
locked cabinet in the researcher’s office.  All survey instruments were identified by the 
code to facilitate organization.    
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3.8 Data analysis 
Once the surveys were completed, all quantitative data was entered into a 
computer program, SPSS version 10, for the purpose of analysis. The analysis was 
conducted in phases and was reported in multiple formats.  First, descriptive data was to 
be presented to describe the number of and demographic information of the sample.  
Means, standard deviations and range of scores of the MSCEIT was to be presented for 
the overall score as well as for the four branch scores.  The Pearson R correlation 
coefficient statistical method was to be utilized to assess the relationship between 
adherence and EQ main and branch scores.  Consultation with an expert statistician was  
sought pre study and post data collection to insure accurate analysis of all data points 
collected.  Overall, the goal of this analysis was to test the researcher’s belief that EQ is 
related to adherence.  Specifically, that higher EQ is strongly related to increased 
adherence.  
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CHAPTER 4. RESULTS 
  
This study examined the relationship between emotional intelligence as measured 
by the MSCEIT and a self-report of HIV positive individual’s adherence to prescribed 
combinational antiretroviral therapy medications (CART).  After receiving Drexel 
University’s Institutional Review Board approval, subjects were recruited from the HIV 
primary care clinic.   After consent was obtained, subjects completed both the written 
questionnaire and the MSCEIT.  Accrual of subjects occurred over a nine-month period 
of time.  Data was entered into a database utilizing SPSS version 11 for analysis. Tables 
were created to allow the researcher to look at the scores of the MSCEIT. Each total 
score and each branch score was correlated with the response question: In the past 7 days 
have you missed any doses of medication?  
Exclusion criteria were limited to an individual’s inability to complete the 
MSCEIT, which took approximately 45 minutes.   
Funding was sought from professional organizations but could not be obtained for 
this project.  The funding was to be used for the remuneration of expenses for each 
individual subject for the sum of $25.  As this was not possible, an incentive was 
substituted.  Each participant was entered into a lottery whose price was fifty dollars.  
 
4.1 Sample 
The goal of this study was to enroll 100 subjects, however accrual proved to be 
difficult.  A purposive, non-random sample of 82 adults who are HIV positive and 
received prescribed antiretroviral medications were successfully recruited via flyers that 
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were placed in the waiting room of a hospital based HIV clinic.  Fifty two data sets from 
these 82 subjects were complete enough for analysis. 
 The sample’s characteristics are presented in Table 4.1.  
 Table 4.1 Demographic Data 
Demographic Data N Percent 
Male 31 60% 
Female 21 40% 
Total 52 100% 
 
Black 42 81% 
White 8 15% 
Other 2 4% 
Total 52 100% 
 
AIDS 28 54% 
HIV+ with symptoms 9 17% 
HIV+ 12 23% 
Missing data 3  6% 
Total 52 100% 
 
The Subjects were 60% men (n=31) and 40% women (n=21)., 81% (n=42) African 
American; 15% (n=8) White and 3%(n=2) listed Other. 53% reported an AIDS diagnosis 
and 17% reported to be HIV + with symptoms, and 23% reported being HIV positive 
without symptoms.  All of the participants in this study took CART on a daily basis.  
57% (n=30) reported that they had not missed a dose of medications in the previous 7 
days. On a 1 to 10 number scale of adherence, designed for this study, in which the 
question stated, “On the scale below, circle the number that best shows how often you 
take your HIV medications.” 1 to 10, in which one meant none of the time and 10 
equaled all of the time. 25 (48%) reported 10 and 13 (25%) reported a 9 meaning that 
they took medications 90% of the time. A mean from these two responses was used as the 
overall adherence score. 
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4.2 Analysis 
The research question for analysis was: Is there a relationship between adherence 
to medications and emotional intelligence as measured by the MSCEIT?  
 The MSCEIT scores are reported like traditional intelligence scales with the 
average score of 100 and a standard deviation of 15.  The MSCEIT yields a total 
emotional intelligence score and the four branch scores, for perceiving emotions, 
facilitating thought, understanding emotion, and managing emotion.   
The total scores indicate an overall capacity to reason with emotion and to use 
emotion to enhance thought.  The total score reflects the capacity to perform well in the 
four branch areas.  The Perceiving Emotions score concerns the ability to recognize how 
the individual and those around them are feeling.  The Facilitating Thought score is the 
ability to employ feelings and enhance thinking; this ability can also be used for more 
effective problem-solving and reasoning, and decision making.  The Understanding 
Emotion score reflects being able to label emotions and reason with them.  The Managing 
Emotions concerns one’s capacity to manage emotions successfully.  The MSCEIT 
scores are computed as percentiles, then positioned on a normal curve with an average 
score of 100 and a standard deviation of 15 (Mayer, Salovey, & Caruso, 2002). 
A Pearson’s r test was performed for correlation – the results are illustrated in 
Table 4.2.  This test was examined for the total MSCEIT and with each of the MSCEIT 
four subscales.  When the total scales and subscales were examined separately, no 
significant relationships were found between any of the MSCEIT branch scores and 
adherence as noted in Table 4.2.   
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Table 4.2 Correlations between MSCEIT Branch scores and Adherence 
Correlations
1.000 .541** .171 .134 .707** .098
. .000 .225 .343 .000 .498
52 52 52 52 52 50
.541** 1.000 .390** .400** .805** -.126
.000 . .004 .003 .000 .385
52 52 52 52 52 50
.171 .390** 1.000 .720** .620** -.168
.225 .004 . .000 .000 .243
52 52 52 52 52 50
.134 .400** .720** 1.000 .663** -.012
.343 .003 .000 . .000 .935
52 52 52 52 52 50
.707** .805** .620** .663** 1.000 -.035
.000 .000 .000 .000 . .808
52 52 52 52 52 50
.098 -.126 -.168 -.012 -.035 1.000
.498 .385 .243 .935 .808 .
50 50 50 50 50 50
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N
EI - BRANCH 1
EI - BRANCH 2
EI - BRANCH 3
EI - BRANCH 4
TOTAL SCORE
Adherence Scale
EI -
BRANCH 1
EI -
BRANCH 2
EI -
BRANCH 3
EI -
BRANCH 4
TOTAL
SCORE
Adherence
Scale
Correlation is significant at the 0.01 level (2-tailed).**. 
 
The MSCEIT total score in this study, which provides an overall index or 
summary of the respondent’s emotional intelligence, demonstrated a range of 33 to 113 
with a mean of 77 with a Std. Deviation of 17.  The MSCEIT branch score 1 – Perceiving 
Emotions had a range of 27 to 136 with a mean of 88 and a standard deviation of 20.  The 
MSCEIT branch score 2 – Facilitating Thought, had a range of 37 to 150, with a mean of 
90 and a standard deviation of 22.  The MSCEIT branch score 3 – Understanding 
Emotions, had a range of 52 to 167 with a mean of 83 and a standard deviation of 21.  
The MSCEIT branch score 4 – Managing Emotions, had a range of 56 to 158, with a 
mean of 81 and a standard deviation of 17.   
There were 3 outlier scores noted, when these were removed the results were still 
similar, see Table 4.3.  
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Table 4.3. EQ Scores 
Score Range  Mean  Std. Deviation  
Total - EQ 33 – 113 77 17 
Branch 1  
Perceiving Emotions 
27 – 136 88 20 
Branch 2 
Facilitating Thought 
27 – 150 90 22 
Branch 3 
Understanding Emotions 
52 – 167 83 21 
Branch 4 
Managing Emotions 
56 – 158 81 17 
 
The mean without the outliers was 78, a median of 76, a mode of 74 with a 
standare deviation of 14.5.  The minimum of this set was 52 and the maximum was 102. 
See Tables 4.4 and 4.5. 
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Table 4.4 Total Score 
TOTAL SCORE
100.0
95.0
90.0
85.0
80.0
75.0
70.0
65.0
60.0
55.0
50.0
TOTAL SCORE
Fr
eq
ue
nc
y
10
8
6
4
2
0
Std. Dev = 14.56  
Mean = 78.2
N = 49.00
 
Table 4.5 Total Score Statistics (without outliers) 
 
 
N Valid 49
 
Mean  78.24
 
Median  76.00
Mode
 
74
Std. 
Deviation
 
14.561
 
 
Minimum  52
Maximum
 
102
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When these results are compared to the test norms this mean was demonstrated as 
being statistically significant when compared with the general population scores. The 
general population scores showed an average of 100 with a standard deviation of 15.   
The scores were also analyzed to determine if there were any gender differences.  
Table 4.6 demonstrates that there were no statistically significant gender differences.  
Table 4.6 Gender distribution 
 
 gender N Mean Std. 
Deviation
Std. Error 
Mean
TOTAL 
SCORE 
MALE 30 77.50 14.292 2.609
 FEMALE 19 79.42 15.295 3.509
 
 
 
 
4.3 Limitations 
THE MSCEIT compares individuals against the normative sample of over 5000 
respondents. Normative data is based on data collected from over 50 research sites from 
diverse geographic locations, the majority of these sites are from the U.S.  In the 50 
research sites, there were statistically reliable sample sizes for each ethnic group; 
however there was a high representation of caucausians and a large proportion had some 
college experience (Mayer et al., 2002).  Another limitation is that the reading level of the 
MSCEIT, a grade eight reading level (Mayer et al., 2002).  While the population at this 
clinic is a general clinical practice, the study population was not assessed for reading 
level.  Most reading information that health care professionals use for patient education 
purposes is at the 5th grade reading level (Quirk, P. 2000). 
 There was great difficulty in accruing subjects.  Many subjects stated that they did 
not have the time to stay to take the test at their regularly scheduled clinic appointment.  
45  
 
While the test instructions stated that the test would take 30 minutes to complete, in 
reality, for this sample, one hour to complete the study was not uncommon.  Given the 
option to return to take the test, after consent was obtained, many subjects did not return 
to complete the test even though they stated that they would do so.  There were also many 
subjects that requested individual remuneration to participate in the study and when they 
found that there was no immediate financial compensation, they refused to participate. 
Many who consented, took the test home to complete and when contacted to return the 
completed test, did not return it.  After over six months of attempts at data collection, a 
decision was made to stop data collection and report on the available data.  
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CHAPTER 5. SUMMARY AND DISCUSSION OF RESULTS 
 
This was an initial exploratory inquiry of a new concept for an old, well-
researched, clinical conundrum – adherence to prescribed medications in a population of 
HIV positive patients. Adherence was measured by subject self report. A minimum of a 
90% adherence rate is necessary for adequate control of the HIV virus.  The literature 
described many factors involved in adherence to medications. The factors most often 
cited in the literature review were: forgetting to take the pills, depression, homelessness, 
substance abuse, being out of town, being asleep, adverse side effects and being too ill 
(Chesney, 2000). The emotional factors of living with HIV were many, including, 
confronting the stigma of HIV, the importance of the relationship of the patient with their 
health care provider and finally, the impact that emotions may play in HIV disease 
progression (Robinson, 2001; Bangsberg, 1997; Chesney, 2000).  These factors all 
contain a high level of emotional content and it was felt that they could be used to 
address the same issues that emotional intelligence (EI) studies. The emotional 
intersection of HIV disease and adherence to prescribed medications became evident in 
the exploration of the literature and it became clear that EI might provide some insight 
into this universal clinical problem. The potential for a correlation of EI, which is the 
ability to perceive emotions, facilitate thought, understand emotions and manage 
emotions, to the problem of adherence to medications, was thought to be an avenue for 
exploration that may prove to be helpful to clinicians to gain insight into caring for 
people living with HIV.    
47  
 
The literature review demonstrated that there could be a link between an 
emotionally charged disease, HIV, and ability to take the treatments successfully.  If a 
relationship was demonstrated, then educational interventions could be designed that 
would improve adherence rates.  However, while the answer to this question increased 
the adherence knowledge base, it did not provide any firm answers to the question of why 
some individuals are better than others about adherence to medications.  
The purpose of this study was to explore the relationship of medication adherence 
and emotional intelligence.  The assumptions at the beginning of this study were that 
there were still challenges to clinicians on reasons why an individual adheres to 
medications and others do not.  EI was thought to be one innovative avenue to explore.  
Measuring emotional intelligence, utilizing the MSCEIT, demonstrates an individual’s 
capacity to reason with emotions and emotional signals, and the capacity of emotions to 
focus and prioritize decision-making.  In this study, no significant relationship was found 
between the total score or the branch scores of the MSCEIT and adherence to medication.  
However an analysis of the total EI scores raised interesting questions that will be 
discussed in this section.  The overall rate of adherence to medications by the individuals 
in this study was that 57%.  This result was similar to other studies looking at adherence 
in HIV disease (Chesney, 2000; USDHHS, 2001).  However, this is still not adequate to 
control the virus because of the problem of viral resistance to the combination of 
medications (Bartlett & Gallant, 2001).   
The Mayer, Salovey & Caruso Theory of Emotional Intelligence served as the 
theoretical framework for this study.  This theory states that EI as an ability can be 
developed and improved upon if found to be deficient.  It was used for this study because 
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of the proposition that HIV is a disease that fosters strong emotions and that the self care 
management by the patient of this disease could be impacted by these emotions.  The 
creators of the MSCEIT, Drs. Mayer, Salovey and Caruso were all contacted thoughout 
the course of this study from conception of the study, during the progress of study and 
finally they were asked to comment on the outcome after reviewing the results.  They 
were supportive throughout this process and they provided some interesting insights to 
the results.  Each of the three theorists noted there were a small number of subjects but 
that the data needed to be explored as it may illuminate trends.  If trends were noted, then 
they could be reported and analyzed.  The major data point evident in this study was the 
markedly low scores of EQ when compared to the national norms.  The most significant 
finding of this study was the overall low EQ scores of the participants.  It is not known if 
this is specific to just this particular study population or whether it can be applied in 
general to individuals living with HIV. Mayer, Salovey and Caruso initially all 
questioned the reliability of the test results. At their request, the results were again 
reviewed, verified and validated by the statisticians at Multi-Health Systems Inc. (MHS), 
the commercial source and scorers of the test.  
Mayer, Salovey and Caruso also felt that it would be difficult to interpret the 
findings because there could be so many plausible explanations, as the MSCEIT had not 
been used with this particular population, of individuals living with HIV disease.  EI has 
been studied with many different groups.  EI has been correlated with problem behavior, 
physical fights, alcohol use, illegal drug use and even knife and gun ownership (Formica, 
1998).  With adolescents, higher scores appeared to have a better social understanding 
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and discourage interpersonal destructive behavior around them (Mayer, Perkins, Caruso 
& Salovey, 2001).  
One of the major reasons for such low results could be the intent in which the 
subjects took the test; one could think that maybe they did not take it seriously.  The 
clinic recruits patients for many types of research studies, new treatment modalities, 
surveys or laboratory monitoring.  In the majority of these studies, the study subjects 
receive monetary compensation.  The notion that they may not have taken the test 
seriously could be a valid point because many requested payment for the study, a few 
refused to proceed with the test and some said they would do it, however their demeanor 
demonstrated reluctance.   
Another reason may be that because these are individuals who are living with 
HIV and AIDS, the symptoms of their illness that may affect their ability to complete the 
45-minute test.  Fatigue and depression are two common co-existing conditions in 
individuals with HIV disease.  The subjects were not screened for either of these two 
entities and it is not known which subjects had these or other symptoms that could have 
been present and affected the testing  on the day that they completed the test. 
Also, this study did not control for educational level.  Nor did the demographic 
data indicate an individual’s reading or educational level.  Printed patient information is 
traditionally at the 4th to 6th grade reading level and the MSCEIT’s reading level is at the 
8th grade.  There was no indication provided by the subjects that they were experiencing 
difficulty with reading the test.  
Peter Salovey commented,  “One begins to wonder whether low EI is a risk factor 
for HIV disease.  These are very low scores!” (personal communication, March, 2003).  
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John Mayer (personal communication, February, 2003) concurred and noted the difficulty 
of working with members of a special group however, he found the trend of the overall 
low scores interesting that the low scores could put one at risk for HIV. 
The literature review for this study demonstrated a relationship between EI and 
use of alcohol and drugs.  Trinidad and Johnson(2002) demonstrated a relationship with 
alcohol and tobacco with lower EQ scores among adolescents.  The study demonstrated 
that individuals with a high EQ might be able to negotiate peer pressure to make healthier 
decisions and not use alcohol or tobacco. However, all of these studies used multiple 
measures to study the various populations. Some measures used were depression surveys 
and specific risk assessments.  This study only looked at one instrument because there no 
evidence that the MSCEIT was ever used to assess a simple relationship with adherence.  
HIV is a disease of risk, and risk assessment has had much attention in identifying 
that assessment of one’s ability to resist risky behaviors that would lead to a negative 
outcomes for many adverse events.  What is known is that there is no one explanation for 
any one risk factor (Graczyk, et al 2001).  One protective attribute that has been 
demonstrated to be effective at decreasing risk taking is being competent within the 
emotional and social context.  Interpersonal skills, problem solving, positive outlook on 
life have all been seen to decrease risk-taking behaviors.  Adherence to CART requires a 
complex approach.  Incorporating methods to improve these interpersonal skills should 
still be considered to improve adherence. One could posit that if further exploration of EI 
with a larger number of subjects was completed, a correlation between risky behaviors 
that could result in HIV infection could be demonstrated.   
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Educational programs have been designed and implemented with a positive 
outcome impact to decrease risky behaviors.  The literature review demonstrated that 
harmful behaviors, like drug and alcohol abuse, often co-exist with an HIV diagnosis 
(Miramontes, 1999; Ungvarski & Flaskerud, 1999).  As a method of preventing HIV 
infection, one may therefore, theoretically, utilize principles of improving emotional 
intelligence to help people negotiate safe sex and avoid abuse of substances that could 
alter one’s ability to negotiate healthy behaviors.  Curriculum can be designed for 
individuals that would enhance their competence with emotionally charged behaviors 
such as drugs used to escape emotions.  These individuals could be looking for emotional 
outlets or support by engaging in sexual practices with multiple partners.   
EI has been demonstrated to have a correlation between a high score and the 
ability to achieve close and affectionate relationships.  If one would look at those 
individuals most at risk for HIV including substance abusers and individuals with 
multiple sexual partners, then the overall low results of this study would make sense.  
However, this study did not look to answer this question. One could conclude that EI 
could certainly still hold some answers to working successfully with individuals at risk 
for HIV disease.  
HIV, as a disease has reached beyond traditional methods of the study of its 
treatment and its science.  Similarly, EI, as a body of knowledge, has reached beyond 
traditional views of intelligence by acknowledging the impact of emotions.  EI continues 
to raise questions about the role of emotions in an individual’s personal as well as social 
functioning.  
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 Research on the care of individuals with HIV disease requires a constant review 
of the literature.  Pradier (2002) continues to study and present his work on psychological 
interventions to improve adherence.  More recently, Paul Farmer (2003) from the 
Harvard Medical School, presented at the 2003 Retrovirus Conference a report 
demonstrating success with utilizing accoumpanteur’s , lay workers from the community,  
as a form of biosocial intervention to improve adherence to CART in Haiti.  These 
accoumpanteur’s are responsible for insuring that the medications are taken every day 
through personal contact.  This work also illustrated trends of diminished AIDS-related 
stigma and a more widespread interest in prevention efforts of people living with HIV. 
This work gives further credence on the importance of emotions in dealing with HIV 
disease.   
While the challenges of the questions of adherence were not answered in this 
research study, more questions have been stimulated for future study.  Of most 
importance would be to longitudinally study a population of similar groups of individuals 
at risk for HIV infection, substance abusers, men who have sex with men, sex workers, 
and to look at the differences in the scores of EI and correlate with sero-conversion of 
HIV disease.  At this point one could design and implement an educational intervention 
improving one’s EI to determine if this decreased transmission of HIV disease among 
high risk individuals.  Another line of inquiry would be to look at a much larger group of 
individuals with HThis study used EI to look at one group of people.  It is limited in that 
EI only gives one view into the complexity of this population.  However, it is this 
researcher’s opinion that it is still useful to explore the use of EI because of the 
demonstrated results of this particular population.  It may, in further studies, demonstrate 
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it’s importance for treatment and educational needs as well as for prevention efforts.  The 
EI framework can act as a guide to design educational interventions as well as to continue 
to be used as a research instrument in this population.  
   Another  key point is the use of the MSCEIT to assess these individuals. There 
are three measures of EI.  EI as proposed by Mayer, Salovey and Caruso, is framed as an 
ability for intelligence.  EI as defined by Reuven Bar-On (1988)  is a part of an 
individual’s personality. Goleman(1998) places EI in the context of performance.  All of 
these theories share common ideas.  While each may use different terminology, the 
essence is in four major domains: self-awareness, self-management, social awareness and 
relationship management (Goleman, 2001).  All three of these theories have an 
assessment tool.  The assessment tools use either the intelligence model like the MSCEIT 
or a performance model like one proposed by Goleman.  MSCEIT was picked because 
this researcher saw adherence as an ability.  However, adherence to medications is not 
only a task that is an ability, but it is also requires performing a healthy behavior. Using 
multiple measures of EI could, again, be used to further define the relationship between 
adherence and EI.  The MSCEIT assessment is complex and it may not be the best tool to 
have used with this particular population.  It measures a reflection on aptitude rather than 
behavior.  Since adherence is complex, it may be necessary to use multiple measures to 
study or assess an individual’s EI.  The answer to that may not be known until further 
studies can be done to compare the different measures against the question of adherence.  
If this researcher were to look at this question again, based upon this experience, 
the design would be improved.  Funding for this study providing a stipend for research 
subjects would be key and used as an incentive to attract more HIV positive individuals 
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to this study.  It would be interesting to also look at the correlation of disease progression 
and possible imaging techniques such as magnetic resonance imaging (MRI) or other 
techniques which could assess the midbrain, the center of emotional control. It might also 
be necessary to assess educational and reading level so that an individual could complete 
the study without frustration. Past histories of abuse, sexual, physical and emotional 
should also be analyzed for their impact. Some qualitative review to explore the 
relationship that the study subject has with the provider would also be helpful. An 
assessment of the individuals risk taking behaviors or tendencies should also be an area 
of future study. 
In summary, adherence remains a complex clinical problem.  People living with 
HIV face many issues, adverse effects from not being able to adhere to medications pose 
challenges not only for the individual patient but also for the concerned health care 
provider.  Improving the patient’s quality of life, while maintaining good control of the 
virus, continues to be a critical part of caring for individuals with HIV.  The complexity 
of this disease as well as its’ seriousness requires novel approaches.  While this study did 
not solve this particular clinical problem of adherence, it provide some potential areas for 
further study as well as potential for new insights into this complex issue.  
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